Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Fumiã, Herman F ^a   Martins, Marcelo L ^b  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY FOR COMPLEX SYSTEMS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CATENIN; DNA; GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; RAS PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOGENESIS; COLORECTAL CARCINOMA; DNA DAMAGE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; MONOTHERAPY; PHENOTYPE; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIMULATION; TUMOR GENE; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

CARCINOGENESIS; CELL HYPOXIA; GENE REGULATORY NETWORKS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASMS; PHENOTYPE; PROTEIN INTERACTION MAPS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84880807874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069008     Document Type: Article

References (47)

1. Weinberg R (2007) The biology of cancer. New York: Garland Science.
2. Kumar V, Abbas AK, Aster JC, Fausto N (2010) Robbins and Cotran pathologic basis of disease. 8th ed. Philadelphia: W.B. Saunders Co.
3. Siegel R, Ward E, Brawley O, Jermal A, (2011) Cancer Statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61: 212-236.
4. Murray CJL, Lopez AD, (1997) Alternative projections of mortality and disability by cause, 1920-2020: Global burden of disease study. Lancet 349: 1448-1504.
5. Clark WH, (1991) Tumour progression and the nature of cancer. Br. J. Cancer 64: 631-644.
6. Martins ML, Ferreira Jr SC, Vilela MJ, (2009) Multiscale model for biological systems. Curr. Opin. Colloid Interface Sci. 15: 18-23 (2010).
7. Kauffman SA (1993) The origins of order: Self-organization and selection in evolution. New York: Oxford University Press.
8. Davidich MI, Bornholdt S, (2008) Boolean network model predicts cell cycle sequence of fission yeast. PLoS One 3(2): e1672.
9. Fauré A, Naldi A, Chaouiya C, Thieffry D, (2006) Dynamical analysis of a generic Boolean model for the control of the mammalian cell cycle. Bioinformatics 22(14): e124.
10. Silva HS, Martins ML, (2003) A cellular automata model for cell differentiation. Phys. A 322: 555-566.
11. Saez-Rodrigues J, Simeoni L, Lindquist JA, Hemenway R, Bommhardt U, et al. (2007) A logical model provides insights into T cell receptor signaling. PLoS Comput. Biol. 3(8): e163.
12. Schlatter R, Schmich K, Vizcarra IA, Scheurich P, Sauter T, et al. (2009) ON/OFF and beyond- A Boolean model of apoptosis. PLoS Comput. Biol. 5(12): e1000595.
13. Mai Zhongxing, Liu Haiyan, (2009) Boolean network-based analysis of the apoptosis network: irreversible apoptosis and stable surviving. J. Theor. Biol. 259: 760-769.
14. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
15. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: The next generation. Cell 144: 646-674.
16. Vogelstein B, Kinzel KW, (2004) Cancer genes and the pathways they control. Nat. Med. 10(8): 789-799.
17. Oda K, Matsuoka Y, Funahashi A, Kitano H, (2005) A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol. 1: 8-24.
18. Calzone L, Gelay A, Zinovyev A, Radvanyi F, Barillot E, (2008) A comprehensive modular map of molecular interactions in RB/E2F pathway. Mol. Syst. Biol 4: 173.
19. Newman MEJ (2010) Networks: An Introduction. New York: Oxford University Press.
20. Evan GI, Vousden KH, (2001) Proliferation, cell cycle, and apoptosis in cancer. Nature 411: 342-348.
21. Lendahl U, Lee KL, Yang H, Poellinger L, (2009) Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10: 821-832.
22. Bunz F (2008) Principles of cancer genetics. Berlin: Springer.
23. Luo J, Solimini NL, Elledge S, (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136: 823-837.
24. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS, (2010) A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 10: 59-64.
25. Stratton MR, Campbell DJ, Futreal PA, (2009) The cancer genome. Nature 458: 719-724.
26. Stephens PJ, Tarpey PS, Davies H, Loo PV, Greenman C, et al. (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature 486: 400-404.
27. Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, et al. (2012) Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486: 405-409.
28. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
29. The Cancer Genome Atlas Research Network, (2011) Integrated genomic analysis of ovarian carcinoma. Nature 474: 609-615.
30. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
31. The Cancer Genome Atlas Research Network, (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
32. The Cancer Genome Atlas Research Network, (2008) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489: 519-525.
33. The Cancer Genome Atlas Research Network, (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 467: 330-337.
34. Greaves M, Maley CC, (2012) Clonal evolution in cancer. Nature 481: 306-313.
35. Ferreira Jr SC, Martins ML, Vilela MJ, (2002) Reaction-diffusion model for the growth of avascular tumor. Phys.Rev.E 65: 021907.
36. Paiva LR, Binny C, Ferreira Jr SC, Martins ML, (2009) A multiscale mathematical model for oncolytic virotherapy. Cancer Res. 69: 1205-1211.
37. KEGG Pathway database, Kyoto Encyclopedia of Genes and Genomes. Available at http://www.genome.jp/kegg/pathway.html.
38. Vanhaesebroeck B, Stephens L, Hawkins P, (2012) PI3K signalling: the path to discovery and understanding. Nat. Rev. Mol. Cell Biol. 13(3): 195-203.
39. Keith B, Johnson RS, Celeste Simon M, (2012) HIF1 and HIF2: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 12(1): 9-22.
40. Yarden Y, Pines G, (2012) The ERBB network: at last, cancer therapy meets systems biology. Nat. Rev. Cancer 12(8): 553-563.
41. Massague J, (2012) TGF signalling in context. Nature Rev. Mol. Cell Biol. 13: 616-630.
42. Anastas JN, Moon RT, (2013) WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 13: 11-26.
43. Cotter TG, (2009) Apoptosis and cancer: the genesis of a research field. Nat. Rev. Cancer 9: 501-507.
44. Batchelor E, Loewer A, Lahav G, (2009) The ups and downs of p53: understanding protein dynamics in single cells. Nat. Rev. Cancer 9: 371-377.
45. Balkwill F, (2009) Tumour necrosis factor and cancer. Nat. Rev. Cancer 9: 361-371.
46. Karin M, Cao Y, Greten FR, Li ZW, (2002) NF-B in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2: 301-310.
47. Smoot M, Ono K, Ruscheinski J, Wang PL, Ideker T (2010) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3): 431-432. Cytoscape is available for download at http://www.cytoscape.com.